EP Patent

EP2413933A2 — Composition of 2,4,6-trifluoro-n-ý6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl¨-benzamide

Assigned to Colucid Pharmaceuticals Inc · Expires 2012-02-08 · 14y expired

What this patent protects

The present invention relates to discloses a pharmaceutical composition of 2,4,6- trifluoro-N-[6-(l-methyl-piperidin-4-ylcarbonyl)-pyridin-2-yl]-benzamide and a pharmaceutically acceptable carrier.

USPTO Abstract

The present invention relates to discloses a pharmaceutical composition of 2,4,6- trifluoro-N-[6-(l-methyl-piperidin-4-ylcarbonyl)-pyridin-2-yl]-benzamide and a pharmaceutically acceptable carrier.

Drugs covered by this patent

Patent Metadata

Patent number
EP2413933A2
Jurisdiction
EP
Classification
—
Expires
2012-02-08
Drug substance claim
No
Drug product claim
No
Assignee
Colucid Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.